History
Asmazol was developed by Dr. Elzo Ferreira in 1997 as a solution to a respiratory problem that cost his father his life.
At that time, there was no effective medication for respiratory failure that did not have side effects, only the already known products that temporarily stabilize the patient, and in many cases, create dependence.
Following his father’s death, Dr. Ferreira concluded that everyone had the right to breathe easily, without having to depend on expensive prescribed medications to treat respiratory symptoms, which caused harmful side effects to health.
It was the death of his father as a result of asthma that put him on a trajectory towards finding a solution, until he found a natural and effective alternative against that respiratory disease.
After years of research and several tests, both in rodents and other animals, a clinical trial was conducted in Brazil with the participation of 1600 volunteers, which demonstrated a 93.6% inhibition.
Asmazol is a powerful anti-inflammatory that expands the airways, allowing air to flow through them, and also contains analgesic properties that relieve pain caused by the lack of air in the bronchi. However, unlike all other medications available in the market, it eliminates the bacteria that trigger crises that inflame the bronchi and airways, and when the patient is stabilized, these bacteria remain lodged in the respiratory system, waiting for the slightest opportunity to generate crises again.
Today, we have Asmazol, a 100% natural product that is effective against respiratory illnesses and does not cause side effects or dependence.
PROPERTIES
No Artificial Flavors
It is a 100% natural product extracted from the Xaxim leaf (Dicksonia Sellowiana).
Zero Cellular Damage
It prevents the stress changes that a cell undergoes due to chemical, infectious, biological, or immunological factors.
Suitable for Vegans
Natural medications are generally gentler on the body and produce fewer side effects.
Antibacterial
Provides adequate protection against microorganisms, biological fluids, and disease transmission.
COVID-19
At the moment, Asmazol is being used in Brazil to treat respiratory crises in COVID-19 patients, with excellent results. The positive effects of this natural medication, originally created to treat asthma and other respiratory conditions, allow people to experience relief from the asphyxia crises caused by the coronavirus.
Anti-inflammatory
COVID-19 inflames the respiratory pathways, causing asphyxia in the person - Asmazol is a potent anti-inflammatory.
Analgesic
COVID-19 causes severe pain in the respiratory system - Asmazol is also an analgesic.
Dilatador
COVID-19 blocks the breathing by causing bronchoconstriction and producing blood clots in the lungs - Asmazol is a bronchodilator that oxygenates blood vessels.
Our Team
Entrepreneur, including Asmazol USA Inc., a company that has exclusive distribution rights for the Asmazol product in the United States. He is originally from Costa Rica, but resides in Austin, Texas, where he has his operations base
Abel Beita
CEO
With over 25 years of experience as an entrepreneur in the USA and Latin America, I founded Asmazol USA together with Abel Beita in 2020. Additionally, I am the founder and President of the Board of Directors of Ágape, a non-profit organization that carries out Health and Education projects in underdeveloped countries.
Herbert Betancourt
CFO y COO
After years of research and development and several clinical trials, Dr. Elzo Ferreira created Asmazol® in 1997, which he successfully patented over 4 years ago in 2019.
Dr. Elzo Ferreira
Creador del Asmazol
Resources
COVID-19
COVID-19 is affecting a large part of the world's population, especially those with pre-existing bronchopulmonary conditions, with acute…
History of Asmazol
Asmazol was developed by Dr. Elzo Ferreira in 1997 as a solution to a respiratory problem that cost…
What is asthma?
Elzo Ferreira (Scientific researcher who developed Asmazol) Asmazol is an inflammatory respiratory disease characterized by recurrent coughing, a…
